INVIVO THERAPEUTICS HOLDINGS CORP. 4
4 · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Mar 26, 2014
Insider Transaction Report
Form 4
Ulich Thomas R
Chief Scientific Officer
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2014-02-24+350,000→ 350,000 totalExercise: $2.33Exp: 2024-02-23→ COMMON STOCK (350,000 underlying)
Footnotes (1)
- [F1]The option is exercisable as to 25% of the shares on the first anniversary of the date of grant, and the remaining shares vest thereafter on a monthly basis in 36 equal monthly installments.